ESR1 and invasive ductal breast carcinoma: Low-grade estrogen receptor (ER)-positive ILC is generally associated with a good prognosis, but some studies have demonstrated that the long-term outcomes of ILC are inferior to those of invasive ductal carcinoma (IDC) of the same stage [16].